Trial intelligence / Profile preview

Impact of CYP2D6 Genotype on Methamphetamine PK/PD

NCT01529892Phase 4Withdrawn

Sponsor
California Pacific Medical Center Research Institute
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methamphetamine, sponsored by California Pacific Medical Center Research Institute. Status: withdrawn.

02

Drugs

methamphetamine

Beyond the preview

Go deeper on NCT01529892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01529892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call